Answered

Westonci.ca is the ultimate Q&A platform, offering detailed and reliable answers from a knowledgeable community. Discover a wealth of knowledge from experts across different disciplines on our comprehensive Q&A platform. Experience the convenience of finding accurate answers to your questions from knowledgeable experts on our platform.

An IRB may suspend or terminate an ongoing clinical study if:

A. Subjects are not being enrolled quickly enough.
B. A drug being used in the trial is approved by the FDA.
C. Instructions from the IRB are not being followed.
D. The clinical trial sponsor conducts an audit at the site.

Sagot :

GinnyAnswer

Final answer:

IRBs protect the rights of clinical trial participants by ensuring informed consent and adherence to FDA regulations.


Explanation:

Institutional Review Boards (IRBs) play a critical role in protecting the rights, safety, and well-being of human subjects participating in clinical trials. IRBs ensure that volunteers give informed consent and that the study follows all ethical and regulatory guidelines outlined by the FDA.


Learn more about Institutional Review Boards (IRBs) in Clinical Trials here:

https://brainly.com/question/31579853


Thank you for choosing our platform. We're dedicated to providing the best answers for all your questions. Visit us again. Thank you for your visit. We're committed to providing you with the best information available. Return anytime for more. Discover more at Westonci.ca. Return for the latest expert answers and updates on various topics.